Finland· FI-REL-REL5346
Bezalip
A bezafibrate product, registered in Finland by Orion Corporation Orion Pharma. The same ATC class is registered in 10 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Bezafibrate is registered in 10 of 19 countries.
Countries holding a registration under ATC C10AB02 (bezafibrate), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Bezafibrate · ATC C10AB02
10 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Franceprice
- Germany
- Italyprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of bezafibrate costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), the median price runs from $0.29 in France to $1.19 in Switzerland — a ×4.1 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bezafibrate · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.19
- IT Italy$0.44
- FR France$0.29
The record
At a glance
Fimea (Finland)- Manufacturer
- Orion Corporation Orion Pharma
- Country
- Finland (FI)
- ATC code
- C10AB02
- ATC class
- Bezafibrate
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C10AB02
Bezafibrate, as other registers publish it.
- FranceBEFIZAL 200 mg, comprimé pelliculéARROW GENERIQUES
- FranceBEFIZAL L.P. 400 mg, comprimé enrobé à libération prolongéeARROW GENERIQUES
- NorwayBezafibrat alAliud Pharma
- GermanyBezafibrat AlAliud Pharma Gmbh
- FinlandBezafibrat GenericsGenerics (UK) Limited
- GermanyBezafibrat Retard AlAliud Pharma Gmbh
- GermanyBezafibrat StadaStadapharm Gmbh
- United KingdomBezafibrate 200mg tabletsA A H Pharmaceuticals Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e0172de9-e7dc-4df1-bfd6-775d934b4f9c GET /v1/drugs/e0172de9-e7dc-4df1-bfd6-775d934b4f9c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.6",
"form": "tabletti",
"route": null,
"ddd_unit": "g",
"strength": "200 mg",
"atc_label": "betsafibraatti",
"ma_number": "10868",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL5346",
"authorised_at": "1992-12-09"
}See everything about bezafibrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.